ClinicalTrials.gg
Not yet recruitingNCT07811843FV-CPUpdated Sep 10, 2026

Effectiveness of Laser Visual Feedback in Postural Control After a Stroke

An interventional study of Intervention in Ictus, Convalescence and Rehabilitation by Recovery of Function, sponsored by Parc Sanitari Pere Virgili. Not yet recruiting at 1 site in Spain. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Parc Sanitari Pere Virgili · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Background: Stroke is one of the leading causes of acquired disability and frequently results in impairments in balance and postural control that affect functional independence. Rehabilitation during the subacute phase is crucial for promoting neurological recovery. Visual feedback using a laser device may facilitate motor learning and postural correction; however, its effectiveness in individuals with subacute stroke has been insufficiently investigated.

Objectives: To evaluate the effectiveness of a laser-based visual feedback exercise program in improving postural control in individuals with subacute stroke. Secondary objectives are to assess its impact on balance, mobility, and functional performance, and to compare outcomes with those achieved through conventional rehabilitation.

Methods: A randomized controlled trial will be conducted in individuals with subacute stroke. Participants will be randomly assigned to either an intervention group, receiving exercises with laser-based visual feedback, or a control group, receiving usual rehabilitation care. Pre- and post-intervention assessments will be performed using validated instruments to measure postural control, balance, and functional capacity.

Discussion: This study addresses the need to identify effective, accessible, and low-cost therapeutic strategies to optimize post-stroke rehabilitation. If proven effective, laser-based visual feedback could enhance functional recovery, promote greater independence in activities of daily living, and help reduce the long-term impact of disability. The findings will provide scientific evidence relevant to clinical practice and may support the incorporation of this approach into neurological rehabilitation programs. In addition, the project will generate valuable knowledge for future research on innovative feedback-based strategies to improve functional recovery following stroke.

Read the detailed description

Background and Rationale

Subacute stroke is commonly associated with impairments in postural control, balance, and movement organization that directly limit functional recovery. Among these impairments, trunk control plays a central role, as it compromises the proximal stability required for maintaining sitting and standing positions, performing transfers, and generating effective motor responses. Therefore, postural control should not be viewed as an isolated rehabilitation goal, but rather as a fundamental basis for overall motor recovery. Likewise, recovery of trunk control has been linked to improvements in upper limb function, and interventions focused on proximal stabilization may enhance arm and hand performance. Taken together, these findings support the concept that optimizing postural control may facilitate both locomotor and manipulative function.

Several studies have shown that visual feedback can improve postural awareness and motor performance. However, evidence regarding the use of laser-based visual feedback in individuals after stroke remains limited. Existing studies have mainly focused on people with chronic stroke or those presenting with pusher syndrome, whereas evidence in the subacute phase is scarce. In particular, there is a lack of research involving participants who meet inclusion criteria similar to those proposed in the present study, namely individuals who are able to initiate standing with assistance. This places the project within a population with greater functional impairment that is currently underrepresented in the scientific literature.

To address this gap, a structured and progressive exercise program based on laser-guided visual feedback has been developed to improve postural control and balance in individuals with subacute stroke.

HYPOTHESES AND OBJECTIVES

Primary Hypothesis

The inclusion of a laser-based visual feedback exercise program as part of conventional physiotherapy treatment in individuals with subacute stroke improves balance.

Secondary Hypothesis

The inclusion of a laser-based visual feedback exercise program in addition to conventional treatment in hospitalized individuals with subacute stroke improves postural control, enhances gait parameters, increases upper-limb functional capacity, and reduces the risk of falls compared with individuals receiving conventional treatment alone.

Objectives

To design and validate laser-based visual feedback exercises aimed at improving balance in individuals with subacute stroke.

To evaluate whether the implementation of a laser-based visual feedback exercise program, in combination with conventional treatment, improves balance in individuals with subacute stroke.

Copilot said:

Study Design

A randomized controlled trial (RCT) will be conducted with two parallel groups (experimental and control) and single blinding of the assessor responsible for evaluating the effectiveness of the intervention. Both participants and investigators will be aware of group allocation.

Study Population

The study is aimed at individuals in the subacute phase of stroke. Procedure

All participants enrolled in the study will be admitted to the Pere Virgili Intermediate Care Hospital in Barcelona after having received care in an acute care hospital. Upon admission, participants will be immediately included in a multidisciplinary rehabilitation program tailored to their individual psychofunctional needs.

The Pere Virgili Intermediate Care Hospital provides several healthcare services, including inpatient care, outpatient care, and long-term care services. Within the inpatient setting, patients with stroke are admitted to the convalescence unit, where they receive a comprehensive rehabilitation-oriented approach. The average length of stay for these patients is approximately 38 days.

Regarding rehabilitation services, patients are assessed on the day of admission by each specialist professional involved in their care. Individuals with stroke receive five 30-minute occupational therapy sessions per week and five 30-minute physiotherapy sessions per week.

Each participant is assigned the same therapist from the initial assessment until completion of treatment. Rehabilitation is individualized according to each participant's deficits, previous functional status, and personal concerns. Physiotherapy combines traditional hands-on techniques, such as the Bobath and Perfetti approaches, with manual therapy, stretching, and massage therapy, together with motor learning-based interventions. These techniques aim to maintain joint range of motion, improve postural control and balance, and facilitate gait retraining.

Intervention Description

As participants are enrolled in the study, they will be randomly assigned to either the experimental group or the control group. Both groups will receive physiotherapy treatment five days per week for four weeks.

The control group will receive the center's usual care, as described above, consisting of 30-minute sessions. The experimental group will receive conventional physiotherapy treatment two days per week and a laser-based visual feedback exercise program three days per week, with each session lasting 30 minutes.

Following the provision of written informed consent, participants will be randomly assigned to one of the two study groups: the control group (CG) or the experimental group (EG).

Before the initiation of any intervention, participants will undergo a baseline assessment (T0). Subsequently, a follow-up assessment at 15 days (T1) and a final assessment at 30 days (T2) will be conducted.

All outcome variables will be assessed at baseline (T0) and at the end of the intervention (T2). Additionally, variables related to balance (S-PASS), as well as fall risk, balance, and gait (Tinetti Scale), will also be assessed at the intermediate 15-day visit (T1).

All assessments will be conducted by a single external assessor who will receive prior training in the administration and scoring of all outcome measures used in the study. The assessor will remain blinded to participants' group allocation throughout the study in order to minimize potential assessment bias.

02

Conditions studied

  • Ictus
  • Convalescence
  • Rehabilitation by Recovery of Function
  • Rehabilitation Frail Elderly Subjects
  • Rehabilitation After Neurological or Orthopaedic Injuries

Browse trials for

03

In context

Convalescence

20 studies on the registry are indexed under Convalescence; 4 are open to participants now.

This study's planned enrollment of 60 is below the median of 96 across 14 interventional studies indexed under Convalescence.

Browse Convalescence studies →

Lead sponsor

Parc Sanitari Pere Virgili is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older admitted from an acute care hospital to a convalescence, rehabilitation, or intermediate care unit for functional recovery following a stroke.
  • Diagnosis of ischemic or hemorrhagic stroke confirmed by magnetic resonance imaging (MRI) or computed tomography (CT).
  • Ability to tolerate assisted standing for a minimum of 10 seconds.
  • Hemodynamically stable individuals, free from fever and disabling pain

Exclusion criteria

Exclusion Criteria:

  • Severe pre-stroke functional dependency, defined as a Barthel Index (BI) score ≤ 60.
  • Diagnosis of dementia with a score ≥ 4 on the Global Deterioration Scale (GDS).
  • Spasticity assessed with the Modified Ashworth Scale (MAS) ≥ 2.
  • Diagnosis of acute confusional syndrome or delirium.
  • Diagnosis of receptive aphasia (Wernicke's aphasia).
  • Visual impairment that prevents the participant from following the laser beam used in the intervention.
  • History of severe balance disorders or traumatic/orthopedic conditions that would prevent participation in the proposed rehabilitation treatment.
  • Absence of balance impairment, defined as a Postural Assessment Scale for Stroke Patients (PASS) score ≥ 24 points.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control

    The control group will receive the center's usual care, as described above, consisting of 30-minute sessions of physiotherapist's exercise.

  • Experimental
    Interventional

    Other: Intervention

Interventions

  • OtherIntervention

    The experimental group will receive conventional physiotherapy treatment two days per week and a laser-based visual feedback exercise program three days per week, with each session lasting 30 minutes.

06

What researchers measure

Primary outcomes

  1. Balance

    Postural Assessment Scale for Stroke Patients (PASS). This scale evaluates postural control in individuals with stroke, particularly during the early stages of recovery.

    Time frame: It will be measured at baseline assessment, at 15 days' visit and at final assessment at 30 days.

  2. Segmental body alignment analysis

    Spinal alignment and immediate postural sway during sit-to-stand transition using a low-profile inertial measurement unit (IMU)-based postural monitoring system that mesures inclination angles in the sagittal, frontal, and transverse planes through two sensors placed at the thoracic and lumbar regions.

    Time frame: It will be measured at baseline assessment and at final assessment at 30 days.

Secondary outcomes

  1. Gait Ability

    Assess through the Functional Ambulation Classification (FAC). This scale classifies walking ability on a scale from 0 to 5, ranging from complete inability to walk to independent ambulation on all surfaces. In addition, the GAITRite® system will be used to analyze spatiotemporal gait parameters, including gait speed, cadence, step length, gait symmetry, base of support, and other indicators related to gait quality.

    Time frame: It will be measured at baseline assessment, at 15 days' visit and at final assessment at 30 days.

  2. Risk of falls

    Assess using the Tinetti Performance-Oriented Mobility Assessment. This tool evaluates balance (16 points) and gait (12 points), with a maximum score of 28 points.

    Time frame: It will be measured at baseline assessment, at 15 days' visit and at final assessment at 30 days.

  3. Upper limb functional capacity

    Assessed using the Stroke Upper Limb Capacity Scale (SULCS). This instrument evaluates upper limb function through 10 hierarchical tasks related to activities of daily living. Scores range from 0 to 10, with higher scores indicating better functional capacity.

    Time frame: It will be measured at baseline assessment, at 15 days' visit and at final assessment at 30 days.

Other outcomes

  1. Sociodemographic data

    Age, sex, handedness, social and family support, previous employment status, educational level, and discharge destination

    Time frame: At baseline assessment

  2. Stroke severity

    Stroke severity assessed using the National Institutes of Health Stroke Scale (NIHSS).

    Time frame: At baseline assessment.

  3. Walking ability Pre-stroke

    Walking ability assessed using the Functional Ambulation Classification (FAC)

    Time frame: At baseline assessment.

  4. Level of independence in activities of daly living Pre-stroke

    Level of independence in activities of daily living measured with the Barthel Index.

    Time frame: At baseline assessment.

  5. Stroke characteristics

    Date of the stroke event, time elapsed until the start of the intervention, type of stroke (ischemic or hemorrhagic), location according to the Oxfordshire Community Stroke Project (OCSP) classification, affected hemisphere and body side, and stroke severity assessed using the National Institutes of Health Stroke Scale (NIHSS).

    Time frame: At baseline assessment.

  6. Type of stroke

    Type of stroke (ischemic or hemorrhagic).

    Time frame: At baseline assessment.

  7. Location of stroke

    Location of stroke according to the Oxfordshire Community Stroke Project (OCSP) classification

    Time frame: At baseline assessment.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2028; primary completion for Sep 2028, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2026
First posted
Sep 10, 2026
StartEst.
Jan 1, 2028
Primary completionEst.
Sep 1, 2028
CompletionEst.
Sep 2028
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07811843
Lead sponsor
Parc Sanitari Pere Virgili
Responsible party
Sponsor
First posted
Sep 10, 2026
Start date
Jan 1, 2028 (estimated)
Primary completion
Sep 1, 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Sep 10, 2026

Study contacts

Ana M Barrios Franquesa, PhD
Contact
abarrios@perevirgili.cat
+ 34 932 594 307

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion